Vestibular Balance Therapy Intervention for Children
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Feb 22, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new home-based therapy program designed to help children with balance problems caused by issues with their inner ear, known as vestibular hypofunction. The main goals are to see if this therapy is practical for families to do at home and to find out if it helps improve balance and function in these children. Participants, aged 6 to 12 years, will first undergo some tests to assess their balance and inner ear function. Then, they will participate in an 8-week program where they practice exercises at home five times a week, with weekly check-ins from a physical therapist to provide guidance and support.
To be eligible for this trial, children must have a confirmed diagnosis of severe to profound hearing loss and must be willing to participate in the therapy. They also need to have had a vision test in the past year or agree to get one. Children with other neurological conditions, those currently receiving vestibular therapy, or those with serious vision problems unrelated to their balance issues will not be able to participate. This study is currently recruiting participants, and the information gathered will help plan a larger trial in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • confirmed diagnosis of severe to profound SNHL
- • age 4-17 years
- • caregiver/child verbal willingness to commit to the home vestibular balance therapy or sham intervention
- • vision screening/testing within 1 year or willingness to get a vision test.
- Exclusion Criteria:
- • neurologic condition other than SNHL
- • inability to read at a kindergarten level or identify pictures
- • currently receiving vestibular therapy
- • uncorrected vision problems unrelated to a vestibular deficit
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Jennifer B Christy, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials